ArticlePloS one2023

A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study.

Emily J Doucette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.